The findings of this study indicate that patients' conditions—assessed through MRS, MRS post‐discharge, NIHSS, atrial fibrillation rhythm, sex, stroke location, and type of stroke—were not significantly associated with the treatment regimens, whether insulin or oral medications. The gene discussed is INS; the disease is atrial fibrillation.